Stage IV Pancreatic Cancer
Showing 1 - 25 of 79
Colorectal Adenocarcinoma, Gastric Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma Trial in Atlanta (Nanoliposomal
Recruiting
- Colorectal Adenocarcinoma
- +13 more
- Nanoliposomal Irinotecan
- Trifluridine and Tipiracil Hydrochloride
-
Atlanta, Georgia
- +2 more
Jan 6, 2023
Metastatic Pancreatic Carcinoma, Stage II Pancreatic Cancer, Stage IIA Pancreatic Cancer Trial in Salt Lake City
Recruiting
- Metastatic Pancreatic Carcinoma
- +6 more
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Oct 31, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- sorafenib tosylate
- +4 more
-
Aurora, Colorado
- +1 more
Sep 8, 2022
Metastatic Malignant Tumor in the Brain, Metastatic Solid Tumor, Recurrent Colorectal Carcinoma Trial in Winston-Salem
Completed
- Metastatic Malignant Neoplasm in the Brain
- +11 more
- Laboratory Biomarker Analysis
- siRNA-transfected Peripheral Blood Mononuclear Cells APN401
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Aug 5, 2022
Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +15 more
- Cisplatin
- +6 more
-
Los Angeles, California
- +1 more
Aug 5, 2022
Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Buffalo (dovitinib lactate,
Completed
- Adenocarcinoma of the Pancreas
- +3 more
- dovitinib lactate
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 20, 2022
Colorectal Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Colorectal Carcinoma Trial in Atlanta (XL888,
Active, not recruiting
- Colorectal Adenocarcinoma
- +14 more
- XL888
- Pembrolizumab
-
Atlanta, Georgia
- +2 more
Jul 5, 2022
Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,
Completed
- Metastatic Pancreatic Adenocarcinoma
- +3 more
- Aldesleukin
- +9 more
-
Detroit, MichiganWayne State University/Karmanos Cancer Institute
Mar 30, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in
Suspended
- Acinar Cell Adenocarcinoma of the Pancreas
- +2 more
- gemcitabine hydrochloride
- +4 more
-
Detroit, Michigan
- +1 more
Feb 2, 2022
Stage IV Pancreatic Cancer, Hepatocellular Carcinoma , Cholangiocarcinoma Trial in Wuhan (Umbilical Cord Blood Derived MAK
Not yet recruiting
- Stage IV Pancreatic Cancer
- Hepatocellular Carcinoma , Cholangiocarcinoma
- Umbilical Cord Blood Derived MAK Immune Cells
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Feb 4, 2022
Stage IV Pancreatic Cancer Trial in United States (cixutumumab, erlotinib HCl, gemcitabine HCl)
Completed
- Stage IV Pancreatic Cancer
- cixutumumab
- +2 more
-
Jonesboro, Arkansas
- +145 more
Jan 13, 2022
Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker
Active, not recruiting
- Acute Myeloid Leukemia
- +66 more
- Best Practice
- +3 more
-
Fullerton, CaliforniaVirginia K Crosson Cancer Center
Jan 31, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Active, not recruiting
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- 6,8-bis(benzylthio)octanoic acid
- +5 more
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 22, 2021
Stage IV Pancreatic Cancer Trial in Ramat Gan (Nivolumab, ipilimumab, Stereotactic body radiation therapy)
Not yet recruiting
- Stage IV Pancreatic Cancer
- Nivolumab
- +3 more
-
Ramat Gan, IsraelSheba Medical Centre
Oct 10, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +3 more
- metformin hydrochloride
- +4 more
-
Cleveland, Ohio
- +1 more
Aug 9, 2021
Recurrent Malignant Solid Tumor, Stage IV Breast Cancer, Stage IV Prostate Cancer Trial in Washington (Canady Helios Cold Plasma
Active, not recruiting
- Recurrent Malignant Solid Neoplasm
- +15 more
- Canady Helios Cold Plasma Scalpel
-
Washington, District of ColumbiaCanady Surgical Group PC
Jul 16, 2021
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in Bronx
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- paclitaxel
- bryostatin 1
-
Bronx, New YorkMontefiore Medical Center
May 18, 2021
Gastrinoma, Glucagonoma, Insulinoma Trial in Stanford (Capecitabine, Temozolomide, Bevacizumab)
Completed
- Gastrinoma
- +8 more
- Capecitabine
- +2 more
-
Stanford, CaliforniaStanford University Medical Center
Apr 8, 2021
Depending on Use of Palliative Care for Advanced Stage of Cancer
Completed
- Stage IV Breast Cancer
- +11 more
- Early palliative care
- Routine hospice care
-
Goyang-si, Gyeonggi-do, Korea, Republic of
- +14 more
Mar 15, 2021
Stage IV Pancreatic Cancer Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))
Terminated
- Stage IV Pancreatic Cancer
- Antineoplaston therapy (Atengenal + Astugenal)
-
Houston, TexasBurzynski Clinic
Dec 16, 2020
Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in United States (OMP-54F28, Nab-Paclitaxel and Gemcitabine)
Completed
- Pancreatic Cancer
- Stage IV Pancreatic Cancer
- OMP-54F28, Nab-Paclitaxel and Gemcitabine
-
Los Angeles, California
- +4 more
Sep 7, 2020
Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in United States (Vantictumab, Nab-Paclitaxel, Gemcitabine)
Completed
- Pancreatic Cancer
- Stage IV Pancreatic Cancer
- Vantictumab
- +2 more
-
Los Angeles, California
- +4 more
Sep 7, 2020
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in San Francisco, Columbus
Completed
- Adenocarcinoma of the Pancreas
- +3 more
- erlotinib hydrochloride
- +2 more
-
San Francisco, California
- +1 more
Jul 29, 2020
Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of the Gallbladder, Adenocarcinoma of Unknown Primary Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +39 more
- oxaliplatin
- +4 more
-
Chicago, Illinois
- +1 more
May 7, 2020